郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Pre- and post-Golgi translocation of glucosylceramide in glycosphingolipid synthesis.

期刊：The Journal of cell biology发表年份：2007作者：David Halter; Sylvia Neumann; Suzanne M van Dijk; Jasja Wolthoorn; Ann M de Mazière; Otilia V Vieira; Peter Mattjus; Judith Klumperman; Gerrit van Meer; Hein Sprong
阅读更多 →

药效评价A monoclonal antibody prevents aggregation of the NBD1 domain of the cystic fibrosis transmembrane conductance regulator.

期刊：Protein engineering, design & selection : PEDS发表年份：2007作者：V Lovato; C Roesli; J Ahlskog; J Scheuermann; D Neri
阅读更多 →

药效评价ABP688, a novel selective and high affinity ligand for the labeling of mGlu5 receptors: identification, in vitro pharmacology, pharmacokinetic and biodistribution studies.

期刊：Bioorganic & medicinal chemistry发表年份：2007作者：Samuel Hintermann; Ivo Vranesic; Hans Allgeier; Armin Brülisauer; Daniel Hoyer; Michel Lemaire; Thomas Moenius; Stephan Urwyler; Steven Whitebread; Fabrizio Gasparini; Yves P Auberson
阅读更多 →

药效评价Neurokinin-3 receptor-specific antagonists talnetant and osanetant show distinct mode of action in cellular Ca2+ mobilization but display similar binding kinetics and identical mechanism of binding in ligand cross-competition.

期刊：Molecular pharmacology发表年份：2007作者：Gaochao Tian; Dee Wilkins; Clay W Scott
阅读更多 →